Joseph Shobhit P, Mirza Shohiab U R, Krupa Jesu, Varghese Shruti I, Kartha Gayathri B, George Oommen K, George Paul V, Jose John, Thomson Viji S
Department of Cardiology, Christian Medical College, Vellore, Tamil Nadu, India.
J Saudi Heart Assoc. 2024 Mar 3;36(1):14-22. doi: 10.37616/2212-5043.1365. eCollection 2024.
This retrospective study sought to determine the feasibility of transcatheter atrial septal defect device closure in patients less than 15 kg, as well as to assess complication rates and the reasons for unsuccessful device closure.
In general, the risks associated with transcatheter atrial septal defect device closure are believed and reported to be relatively low, but the evidence stems from trials involving adults and older children. Current guidelines do not recommend atrial defect closure in device closure in children <15 kg, due to limited data available for feasibility and safety of device closure in this group of patients.
Retrospective review of all patients who underwent elective transcatheter closure of ostium secundum atrial septal defect between September 2013 to February 2022. We excluded all children above 15 kg, as well as those with complex congenital heart defects. Major and minor complications were predefined and indications for referral were evaluated.
We identified 81 patients meeting criteria with a median procedural age of 3 years (1 year-8 years), and median weight of 12 kg (4-15 kg). Successful device closure was achieved in 95.1% (77/81) and in 4.9% (4/81), the procedure was aborted. There was 1 major (1.2%) and 1 minor (1.2%) complication, total complication rate (2.4%). 100% of the referrals had right heart enlargement and exertional dyspnoea, 18.5% had recurrent lower respiratory tract infection and 9.9% had failure to thrive. Rate of resolution of residual shunt was 95.1%. at post-procedure day 1 and 98.8% at post-procedure 3 and 6 months respectively.
Percutaneous atrial septal defect closure can be done effectively and safely in symptomatic children weighing less than 15 kg in experienced centres. However, deferral for closure until the historically established timeline of around 4-5 years of age should be strongly considered in asymptomatic children.
本回顾性研究旨在确定体重小于15公斤的患者行经导管房间隔缺损封堵术的可行性,并评估并发症发生率及封堵失败的原因。
一般认为并报道,经导管房间隔缺损封堵术相关风险相对较低,但证据来源于涉及成人和大龄儿童的试验。由于该组患者封堵术可行性和安全性的数据有限,目前指南不推荐对体重<15公斤的儿童进行房间隔缺损封堵术。
回顾性分析2013年9月至2022年2月期间所有接受择期经导管继发孔房间隔缺损封堵术的患者。我们排除了所有体重超过15公斤的儿童以及患有复杂先天性心脏病的儿童。预先定义了主要和次要并发症,并评估了转诊指征。
我们确定了81例符合标准的患者,手术年龄中位数为3岁(1岁至8岁),体重中位数为12公斤(4至15公斤)。95.1%(77/81)的患者成功完成封堵,4.9%(4/81)的患者手术中止。有1例主要并发症(1.2%)和1例次要并发症(1.2%),总并发症发生率为2.4%。100%的转诊患者有右心扩大和劳力性呼吸困难,18.5%有反复下呼吸道感染,9.9%有生长发育迟缓。术后第1天残余分流消失率为95.1%,术后3个月和6个月分别为98.8%。
在经验丰富的中心,对于有症状、体重小于15公斤的儿童,经皮房间隔缺损封堵术可以有效、安全地进行。然而,对于无症状儿童,应强烈考虑推迟至约4至5岁这一既往确定的时间进行封堵。